Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Abaxis Inc (ABAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,898,210
  • Shares Outstanding, K 22,870
  • Annual Sales, $ 244,700 K
  • Annual Income, $ 27,180 K
  • 36-Month Beta 1.30
  • Price/Sales 7.77
  • Price/Cash Flow 48.41
  • Price/Book 6.48
  • Price/Earnings ttm 63.92
  • Earnings Per Share ttm 1.30
  • Most Recent Earnings 0.42 on 04/26/18
  • Next Earnings Date 08/02/18
  • Annual Dividend & Yield 0.72 (0.87%)
  • Most Recent Dividend 0.180 on 05/31/18
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/18
See More
  • Average Estimate 0.35
  • Number of Estimates 4
  • High Estimate 0.37
  • Low Estimate 0.32
  • Prior Year 0.28
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
82.91 +0.11%
on 07/05/18
83.37 -0.44%
on 07/17/18
-0.01 (-0.01%)
since 06/29/18
3-Month
65.51 +26.70%
on 05/08/18
83.98 -1.17%
on 05/18/18
+16.43 (+24.68%)
since 04/30/18
52-Week
43.66 +90.11%
on 09/19/17
83.98 -1.17%
on 05/18/18
+35.38 (+74.30%)
since 07/28/17

Most Recent Stories

More News
Zoetis Completes Acquisition of Abaxis, a Leading Global Provider of Veterinary Point-of-Care Diagnostic Instruments

--Enhances Zoetis' presence in veterinary diagnostics, a category of the animal health industry with approximately 10% compound annual growth over the last three years(1)

ABAX : 83.00 (-0.11%)
ZTS : 91.11 (-0.47%)
Veterinary Diagnostics Market to Hit 9.3% CAGR to 2023, Led by Animal Health Expenditure and Pet Insurance

ReportsnReports added veterinary diagnostics market research, it includes the companies like IDEXX Laboratories, Inc. (U.S.), Abaxis, Inc. (U.S.), Neogen Corporation (U.S.), Heska Corporation (U.S.), Thermo...

ABAX : 83.00 (-0.11%)
ZTS : 91.11 (-0.47%)
IDXX : 241.37 (-0.78%)
QGEN : 37.12 (-0.46%)
NEOG : 83.67 (-0.26%)
HRC vs. ABAX: Which Stock Is the Better Value Option?

HRC vs. ABAX: Which Stock Is the Better Value Option?

ABAX : 83.00 (-0.11%)
HRC : 94.91 (+0.30%)
Is Abaxis (ABAX) Outperforming Other Medical Stocks This Year?

Is (ABAX) Outperforming Other Medical Stocks This Year?

ABAX : 83.00 (-0.11%)
Is Abaxis (ABAX) Outperforming Other Medical Stocks This Year?

Is (ABAX) Outperforming Other Medical Stocks This Year?

ABAX : 83.00 (-0.11%)
Rigrodsky & Long, P.A. Files Class Action Suit Against Abaxis, Inc.

Rigrodsky & Long, P.A.:

ABAX : 83.00 (-0.11%)
Abaxis (ABAX) and Zoetis Merger Deal Crosses HRS Hurdle

With the adoption of Abaxis' (ABAX) point-of-care diagnostic instruments post acquisition, the combined entity's veterinary diagnostics category should grow faster than the animal health industry.

GHDX : 54.25 (+1.14%)
ABAX : 83.00 (-0.11%)
ZTS : 91.11 (-0.47%)
ALGN : 348.64 (-0.73%)
Wired News - Zoetis Announces HSR Clearance for Acquisition of Animal Health Company Abaxis

LONDON, UK / ACCESSWIRE / July 10, 2018 / If you want access to our free research report on Zoetis Inc. (NYSE: ), all you need to do is sign up now by clicking the following link as the Company's latest...

ABAX : 83.00 (-0.11%)
ZTS : 91.11 (-0.47%)
Zoetis (ZTS) Tides Over HSR Hurdle for Abaxis Acquisition

Zoetis' (ZTS) waiting period under the HSR Act ends. It is related to its proposed merger with Abaxis for a purchase consideration of roughly $2 billion in aggregate.

GHDX : 54.25 (+1.14%)
ABAX : 83.00 (-0.11%)
ZTS : 91.11 (-0.47%)
TARO : 107.50 (-0.11%)
Top Ranked Momentum Stocks to Buy for July 9th

Top Ranked Momentum Stocks to Buy for July 9th

ABAX : 83.00 (-0.11%)
ADSW : 25.60 (+1.11%)
ADM : 50.51 (+0.72%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Falling.

See More Share

Trade ABAX with:

Business Summary

Abaxis, Inc. is a worldwide developer, manufacturer and marketer of portable blood analysis systems that are used in a broad range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements. Their mission is to improve the efficiency of...

See More

Key Turning Points

2nd Resistance Point 83.32
1st Resistance Point 83.16
Last Price 83.00
1st Support Level 82.92
2nd Support Level 82.84

See More

52-Week High 83.98
Last Price 83.00
Fibonacci 61.8% 68.58
Fibonacci 50% 63.82
Fibonacci 38.2% 59.06
52-Week Low 43.66

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar